SEPN Overview

Company Profile

Related stocks

URGN • United States

UroGen Pharma Ltd.

36.83 USD

1.8B USD 1Y +113.4%

ZBIO • United States

Zenas BioPharma, Inc.

27.26 USD

1.78B USD 1Y +1.3%

GENB • United States

Generate Biomedicines, Inc.

14.34 USD

1.84B USD

NTLA • United States

Intellia Therapeutics, Inc.

13.07 USD

1.83B USD 1Y -48.5%

XNCR • United States

Xencor, Inc.

24.63 USD

1.83B USD 1Y +97.6%

BHVN • United States

Biohaven Ltd.

12.08 USD

1.82B USD 1Y -22.2%

GPCR • United States

Structure Therapeutics Inc.

25.54 USD

1.82B USD 1Y -9.8%

NUVB • United States

Nuvation Bio Inc.

5 USD

1.76B USD 1Y +33.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

89.8% p.a.

Max Drawdown (3Y)

-81.5%

Sharpe Ratio (3Y)

0.33

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections